The training courses
ISTDP-UK trainers and Core Trainings are accredited by the International Association of Experiential Dynamic Therapies (IEDTA), the international accrediting body for the group of psychotherapies that have developed based on ISTDP principles.
On successful completion of the three-year Core Training, participants will receive accreditation with IEDTA.
ISTDP-UK training programmes are delivered in consultation with Robert J. Neborsky and are based on the Attachment Based ISTDP approach developed by him. Attachment Based ISTDP relies on research from the child study laboratory of Mary Main regarding attachment security.
2 Day Introduction to ISTDP
Dates 25 & 26 February 2022. 1 & 2 April 2022. 30 September & 1 October 2022 Venue Bristol Cost £450
This ‘stand-alone’ two-day course is suitable for those wanting to learn more about the method as well as for those who want to continue onto the three-year full training in ISTDP.
During the two days, participants are given an overview of the theory and metapsychology of ISTDP and learn the core principles of this approach within a small group setting. Lectures, role-play and videotaped ISTDP therapy sessions are used to demonstrate effective interventions to:
- Develop an effective focus for change
- Assess and regulate unconscious anxiety
- Identify maladaptive defence patterns
3 Year Core Training in ISTDP
Advanced Training Course in ISTDP
Dates New group starting February 2022 Venue Online & Bristol Cost £1650
This one-year course on advanced techniques in ISTDP is suitable for qualified practitioners who have successfully completed any Core Training in Intensive Short-Term Dynamic Psychotherapy.
Due to COVID restrictions, we are running this course online as well as some face to face meetings. The small group will meet six times a year for one day.
The course comprises lectures and supervision and will focusses on topics such as: psycho-diagnosis, building of ego-adaptive capacity, working with syntonic character defences, somatic symptom disorders, and the issue of treatment resistance.